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OBJECTIVE: To test the hypothesis that pulse pressure respiratory variation (PPV) amplification, observed in hypovolemia, can 
also be observed during sodium nitroprusside (SNP)-induced vasodilation. 
INTRODUCTION: PPV is largely used for early identification of cardiac responsiveness, especially when hypovolemia is suspected. 
PPV results from respiratory variation in transpulmonary blood flow and reflects the left ventricular preload variations during respi-
ratory cycles. Any factor that decreases left ventricular preload can be associated with PPV amplification, as seen in hypovolemia. 
METHODS: Ten anesthetized and mechanically ventilated rabbits underwent progressive hypotension by either controlled hem-
orrhage (Group 1) or intravenous SNP infusion (Group 2). Animals in Group 1 (n = 5) had graded hemorrhage induced at 10% 
steps until 50% of the total volume was bled. Mean arterial pressure (MAP) steps were registered and assumed as pressure targets 
to be reached in Group 2. Group 2 (n = 5) was subjected to a progressive SNP infusion to reach similar pressure targets as those 
defined in Group 1. Heart rate (HR), systolic pressure variation (SPV) and PPV were measured at each MAP step, and the values 
were compared between the groups. 
RESULTS: SPV and PPV were similar between the experimental models in all steps (p > 0.16). SPV increased earlier in Group 2. 
CONCLUSION: Both pharmacologic vasodilation and graded hemorrhage induced PPV amplification similar to that observed in 
hypovolemia, reinforcing the idea that amplified arterial pressure variation does not necessarily represent hypovolemic status but 
rather potential cardiovascular responsiveness to fluid infusion. 
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INTRODUCTION
Many critically ill patients are hemodynamically 
unstable. This instability may be caused by cardiac 
dysfunction, vasodilation, hypovolemia or the association 
of these factors. Independent of hemodynamic behavior, 
patients are subjected to volume infusion or withdrawal at 
some point during their hospitalization.1-4 In these situations, 
the correct and early definition of intravascular content 
is essential to avoid tissue ischemia, resulting in multiple 
organ dysfunction.4-6 Therefore, the correct diagnosis of 
fluid status must be accurately and rapidly achieved to avoid 
both hypoperfusion related to volume depletion and fluid 
overload followed by unnecessary infusion. Hence, accurate 
hemodynamic monitoring methods are necessary to help us 
to perform fluid management.4,7,8
Pulse pressure respiratory variation (PPV) has generally 
been demonstrated to be much more accurate for the 
detection of fluid responsiveness than cardiac filling 
pressures.9-12 The former method is also more reliable 
than other dynamic parameters, such as systolic pressure 
respiratory variation (SPV) or stroke volume respiratory 
variation (SVV), and it can recognize volume contraction 
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earlier than the others.9,10,13 Hence, PPV has become largely 
recommended to guide volume expansion in patients with 
hemodynamic instability.9-12
We have recently reported pulse oximetry wave variation 
as a noninvasive tool to assess volume status in cardiac 
surgery14. However, positive pressure ventilation promotes 
cyclical changes in stroke volume (SV), and is coupled 
with arterial pulse pressure changes. SV and arterial pulse 
pressure rise during inspiration. Conversely, SV comes 
down during expiration. PPV is directly influenced by the 
SV and is mathematically expressed as the percentage of 
the variation between systolic and diastolic pulse pressure 
obtained in a single ventilatory cycle. Patients with low 
PPV are insensitive to cyclic changes in preload induced by 
mechanical ventilation, and they operate on the flat portion 
of the Frank-Starling curve (non-responders). On the other 
hand, when PPV is high, patients are operating on the steep 
portion of the Frank-Starling curve and can respond with an 
increase in SV after fluid infusion (responders).9,13,15,16 
However, the method has some limitations, and they need 
to be accounted for. The magnitude of PPV variations can be 
influenced not only by the cardiovascular responsivity status 
but can also be related to spontaneous breathing, arrhythmia, 
tidal volume above 10 ml/kg or below 8 ml/kg, right 
ventricular dysfunction, pulmonary arterial hypertension, 
intrinsic or extrinsic positive end-expiratory pressure 
(PEEP), and alterations in arterial wall stiffness such as the 
one which occurs with vasodilation.9,16,17
Pizov et al. (1988) observed that both absolute 
(hemorrhagic shock) and relative (pharmacologic 
vasodilation) hypovolemia are related to the amplification 
of SPV in anesthetized dogs. They observed that, under 
absolute hypovolemic conditions, SPV is greater when 
compared with SPV during pharmacological vasodilation.18 
More recent publications found that PPV has greater 
accuracy than SPV at evaluating cardiovascular responsivity 
in critically ill patients.9,11,12 
These data show the relevance of clinical knowledge 
about the behavior of PPV during vasodilation. Hence, 
comparing PPV behavior in hypovolemic conditions and 
under vasodilation may be useful in clinical settings.
The purpose of this study is to compare the effects of 
hypovolemia and pharmacological vasodilation on arterial 
pressure traces. 
MATERIALS AND METHODS
Study design and animal preparation 
This experimental, observational and comparative 
study was performed at the Experimental Surgical Center. 
The study was approved by an Institutional Research 
Consulting Board. Twenty-one New Zealand male rabbits 
(1.6 kg ± 0.3 kg) were arbitrarily divided into two groups. 
Animals in Group 1 (n = 5) had induced hemorrhage, and 
Group 2 (n = 5) had induced pharmacologic hypotension 
with a SNP infusion. Five rabbits were used in a pilot 
study, and six rabbits died before the conclusion of the 
experiment. The animals were fasted for 12 h before 
the start of the experiment, and free access to water was 
allowed. 
The animals received subcutaneous pre-anesthetic 
medication (ketamine 15 mg/kg, acepromazine 1 mg/kg 
and dexamethasone 150 mg/kg), the auricular vein was 
cannulated with a 24-gauge catheter and a 0.9% NaCl 
solution was started at 5 mL/kg/h. The rabbits were placed 
in the supine position. General anesthesia was started and 
maintained with venous ketamine (2 mg/kg) and 1% inhaled 
halothane with oxygen flow at 2 L/min.
After a tracheotomy was performed, an endotracheal 
tube was inserted midway along the trachea, and controlled 
mechanical ventilation was started with a neonatal ventilator 
(Bear BP-200, Bear medical systems, Inc., Riverside, CA, 
USA). The ventilation settings were: tidal volume of 15 mL/
kg, respiratory frequency of 25 rpm, fractional concentration 
of oxygen (FiO2) at 100% and PEEP of 3 cm H2O, resulting 
in a peak airway pressure between 10 and 15 cm H2O. 
The right carotid and internal jugular vein were 
cannulated with 22-gauge polyethylene catheters to monitor 
arterial pressure and fluid administration and to induce the 
controlled hemorrhage. In order to replace any deficits that 
may have taken place while fasting prior to the experiment, 
rabbits were infused with 4 mL/kg of 0.9% NaCl. After 30 
min of cardiovascular stabilization, the hemorrhagic shock 
was initiated. 
The arterial catheter was connected to a pressure 
transducer (DTX Plus DT-4812NA, Becton & Dickinson, 
Franklin Lakes, NJ, USA) that was linked to a multiparametric 
monitor (S/5 Light-Solo®, Datex-Ohmeda, Helsinki, 
Finlândia) to record continuous heart rate (HR) and digital 
arterial pressure. These parameters were transferred to 
a personal computer with S/5 Collect® (Datex-Ohmeda, 
Helsinki, Finlândia) software. 
Experimental protocol
Experimental procedures were performed as follows. 
Controlled hemorrhagic shock (Group 1): after baseline 
(T0) data recording (HR, arterial pressure, SPV and PPV), 
manual blood withdrawal through the central venous 
catheter was performed with steps of 10% of the estimated 
volemia (80 mL/kg) at a rate of 5 mL/minute, until 50% of 
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the total volume was bled. At each bleeding step (T1-10%, 
T2-20%, T3-30%, T4-40% and T5-50%), hemodynamic 
data were digitally recorded again. Pharmacologic 
hypotension (Group 2): the mean values of mean arterial 
pressure (MAP) obtained at each of the bleeding steps 
observed in Group 1 were defined as the target to be 
reached with SNP infusion. The SNP infusions were 
started at 0.5 mg/kg/min. Progressive SNP dose increments 
were performed until the MAP targets were reached. 
Hemodynamic data were digitally recorded at each induced 
hypotension step. 
The pressure waveforms were analyzed off-line on 
a personal computer. We identified the arterial pressure 
respiratory variation and the systolic and diastolic pressures 
(Figure 1). In each respiratory cycle, systolic pressure and 






min and Ppmin) were identified. Respiratory 
changes in SPV and PPV (in %) were calculated using the 
following formulas10: 
SPV (%) = 100 x (Ps
max
 - Ps
min) / [(Psmax + Psmin) / 2];
PPV (%) = 100 x (Pp
max
 - Pp
min) / [(Ppmax + Ppmin) / 2].
After the experiments, all animals were euthanized by 
intravenous pentobarbital overdose and hypertonic potassium 
solution.
Statistical methodology
For the statistical analysis, NCSS: Statistical Software 
2000 and PASS 2000: Power Analysis & Sample Size 
were used. The results were expressed as the mean ± 
standard error of mean (SEM). Data were compared using 
Student’s t-test for continuous variables. Mixed ANOVA 
was conducted to analyze repeated measures between group 
interactions. All tests were two-tailed, and a P value < 0.05 
was considered statistically significant.
RESULTS
All animals were hemodynamically stable at baseline 
(BL). Animal weight ranged from 1.3 kg to 1.9 kg. The 
estimated average volemia (80 mL/kg) ranged from 104 
mL to 152 mL. The bleeding time at each step ranged from 
10 minutes to 15 minutes depending on animal weight. 
Sequential hemodynamic changes related to the amount of 
blood volume removed as well as with SNP administration 
are shown in Figure 2. The SNP doses necessary to reach 
predefined MAP goals ranged from 22 mg/kg/min to 56 
mg/kg/min. Six animals died during the experimental 
procedures. 
Mixed ANOVA results indicated a significant effect in 
MAP at every steps of the experiment, but there were no 
differences between groups, in a marginal non-significant 
level (F = 2.662, p = 0.053, partial eta2 = 0.27). Hence, 
hemorrhage and SNP groups had similar MAP values at each 
step of the procedure. The same procedure was conducted 
to analyze HR, PPV and SPV. HR was different between 
groups (p < 0.001), but PPV (p = 0.71) or SPV (p = 0.31) 
did not show any differences.
Although there are no MAP differences between the 
groups, this parameter presented earlier decreases during SNP 
infusion (T1, p < 0.03) compared to the decrease observed in 
the hemorrhagic shock model (T2, p < 0.03). PPV changed 
significantly in the two groups at T3 when compared to the BL 
values (p < 0.05). On the other hand, SPV was significantly 
reduced at T1 (p < 0.04) in the SNP group, while the reduction 
became significant at T4 in the hemorrhage group (p < 0.04). 
HR increased at T3 during SNP administration (p < 0.02). HR 
remained unchanged during all stages of blood withdrawal (p 
= 0.12), while significant changes were observed in the SNP 
group at T2 (p < 0.03).
DISCUSSION
In the present study, we compare the implications of 
two shock models (hemorrhagic shock and pharmacologic 
vasodilation) on arterial pressure traces. We observed that 
PPV was similar during all steps in both shock models. 
These results show that exclusive vasodilation (relative 
hypovolemia) can be confused with real hypovolemic states 
in clinical settings, especially when deliberate hypotension 
is necessary. Aortic pulse pressure is directly proportional 
to SV and is reflected in the peripheral pulse pressure. At 
the same time, respiratory PPV are inversely proportional 
to SV and cardiac output (CO). This dependence between 
pulse pressure and SV explains the PPV amplification 
observed in hypovolemic status.16,17 During pharmacological 
hypotension, SV usually remains normal or reduced, while 
Figure 1 - The representative trace shows the arterial pressure fluctuations 
during mechanical ventilation. The systolic pressure is maximal during 
inspiration and declines in expiration. Similarly, arterial pulse pressure is 
maximal during inspiration and minimal during expiration. Pp
max
, maximal 
arterial pulse pressure; Pp
min, minimal arterial pulse pressure; Psmax, maximal 
arterial systolic pressure; Ps
min, minimal arterial systolic pressure. 
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vascular resistance is low.18,19 Considering the strong relation 
between PPV and SV, we expected that PPV would be 
reduced in the SNP group. However, our findings show 
similar increments of PPV in both the hypovolemic and 
pharmacological hypotension models. 
In our model, requiring small animals, the SNP doses 
necessary to reach predefined MAP goals were greater than 
those habitually used in humans. The SNP has arterial and 
venous vasodilatory capacities, the latter being unpredictable 
as opposed to the arterial capacity, which is reflected by 
the arterial pressure. Through its venous action, the large 
SNP dosage could have increased microvascular volume 
redistribution, decreased the stressed venous volume and 
thus reduced the effective blood volume, SV and PPV. 
The significant HR increments observed in the SNP group, 
probably for CO compensation, reinforce the possibility of 
an SV drop. However, this is only a hypothesis that should 
be confirmed with a more appropriate model. On the other 
hand, there was no increase in HR in the hypovolemic group. 
Neural strategies underlying autonomic control may vary 
depending on the rate of blood loss. Hence, the rate of blood 
loss has an important impact on autonomic regulation during 
severe hemorrhage. Porter et al. observed that, depending 
on blood loss rate, HR may vary in the opposite direction. 
Another factor that may be involved in maintaining the 
heart rate in the hemorrhage group is the rate of suppression 
of autonomic nervous system activity triggered by the 
anesthesia. Kawase et al. observed heart rate lowering during 
hemorrhage and isoflurane anesthesia.20,21 On the other hand, 
NPS causes tachycardia, either through vasodilation or 
NO donation. This feature is important because high SNP 
doses were used, and the heart rate in the SNP group was 
significantly higher than the one in the hemorrhage group.
Hypotension during SNP administration is produced by 
simultaneous reductions of preload and afterload.18,19 Hence, 
the role of arterial compliance during mechanical ventilation 
must also be considered for this analysis. Ventricular 
afterload normally drops during mechanical inspiration 
because of the increased intrathoracic pressure (ITP). The 
decrease in afterload contributes to an increase in left 
ventricular SV, which increases systolic arterial pressure and 
arterial pulse pressure.19,22 SNP reduces afterload and may 
exacerbate the respiratory fluctuation of left ventricular SV, 
with a corresponding exaggeration in PPV and SPV.18,19,22 
On the other hand, the adrenergic response, frequently 
present in hypovolemic states, probably partially reduces 
PPV and SPV in the hemorrhage group by increasing arterial 
elasticity and/or shifting blood from an unstressed to a 
stressed volume. This adrenergic effect on PPV and SPV 
was previously demonstrated with norepinephrine infusion 
during a hemorrhagic shock model.23 The authors observed 
that norepinephrine could significantly reduce the value of 
PPV and SPV and mask a true intravascular volume deficit.23
The present study did not detect an SPV statistical 
difference between vasodilation and hemorrhage. SPV 
behavior, such as the one that occurred with PPV, was 
Figure 2 - Hemodynamic variables measured during experiment steps in 
the hemorrhage and nitroprusside (SNP) groups. Steps T1, T2, T3, T4 and 
T5 correspond to 10%, 20%, 30%, 40% and 50% of blood removal from 
estimated volemic state (hemorrhage group). In the SNP group, mean arte-
rial pressure (MAP) achieved corresponds to the MAP observed at each 
bleeding step set in the hemorrhage group. Bars “a” (Hemorrhage) and “b” 
(SNP) correspond to p < 0.05 to baseline (Student’s t-test). An asterisk shows 
statistical differences (p < 0.05) between groups (ANOVA test). 
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slightly greater in the SNP group than in the hemorrhage 
group. By contrast, Pizov et al. demonstrated that, 
during NPS infusion in a dog model, SPV was not as 
strongly affected by pharmacologic hypotension as in the 
hemorrhagic scenario.18 These conflicting results may also 
be affected by an intense reduction in preload and afterload 
caused by the excessive SNP dosage used in the present 
study. Additionally, in the present study, the anesthetic 
procedure included inhalatory anesthesia with halothane, 
which could have amplified the vasodilatory properties of 
SNP.24
In the SNP group, the SPV amplification was increased 
earlier (T1) than in the hemorrhage group (T4), contrasting 
with the PPV alteration that occurred at the same time in 
both groups (T3). The systolic and pulse pressure reduction 
seen during expiration reflects the expiratory reduction of 
SV. Conversely, systolic and pulse pressure increments 
observed in the inspiratory phase are proportional to the 
increases in SV. Besides the SV increments, the inspiratory 
gain observed in systolic pressure is additionally influenced 
by the aortic surrounding pressure, unlike PPV, which is 
basically conditioned by SV variations. Hence, at least 
a fraction of SPV results from airway pressure (P
aw
) 
transmission to the vascular bed. In addition, when ITP is 
minimal during expiration, aortic compliance increases, 
arterial systolic pressure drops and SPV increases.16,17,22,25 
This expiratory compliance increment may be exaggerated 
with SNP administration, and expiratory pulse pressure 
drops deeply, resulting in a major SPV. Hence, the earlier 
SPV amplification observed in the SNP group may reflect 
the transmitted airway pressure rather than SV. 
When PPV is evaluated, systolic and diastolic blood 
pressures are measured simultaneously at the same 
inspiratory ITP and at the same expiratory ITP. The 
variable effect of ITP on aortic transmural pressure is 
therefore removed, making PPV a more reliable indicator 
of preload than SPV. However, we have to consider that, 
under vasoplegic conditions, expiratory pulse pressure is 
minimal as a result of increased aortic compliance without 
any augmentation of the surrounding aortic pressure.16,22,25
This study allowed us to conclude that PPV amplification 
is similar in hypovolemia or pharmacologic vasodilation 
induced by sodium nitroprusside. SPV is influenced sooner 
by thoracic pressurization in the vasodilation model and may 
be affected by a stronger transmission of extra mural aortic 
pressure and reduced arterial compliance. Caution should be 
exercised before assuming that arterial dynamic evaluation is 
only a marker of intravascular volume status.
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